Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 8587634)

1.

Trend evaluation of aluminium in uraemic patients on chronic hemodialysis.

Di Iorio BR, Scarpino L, Bruno A, Confessore A, Gaudiano G, Altieri C, Smilari F, Papaleo D, Cosentino G, Terracciano V.

Nephron. 1995;71(4):471-2. No abstract available.

PMID:
8587634
2.

[Aluminum concentration in blood of hemodialysis patients and its clinical importance].

Skarupskiene I, Kuzminskis V, Abdrachmanovas O, Ryselis S, Smalinskiene A, Naginiene R.

Medicina (Kaunas). 2003;39 Suppl 1:104-8. Lithuanian.

3.

Silicon in chronic hemodialysis patients.

Hosokawa S, Morinaga M, Nishitani H, Maeda T, Yoshida O.

ASAIO Trans. 1987 Jul-Sep;33(3):260-4. No abstract available.

PMID:
3314921
4.
5.

Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?

Friga V, Linos A, Linos DA.

Nephron. 1997;75(1):48-53.

PMID:
9031270
6.

[Causes of hyperaluminemia in patients maintained on hemodialysis].

Balezina OA, Ermolenko VM, Bel'skii NK, Nebol'sina LA, Segel'man VS.

Ter Arkh. 1982;54(7):85-6. Russian. No abstract available.

PMID:
7135231
7.

[Clinical evaluation of osteocalcin in chronic hemodialysis patients].

Nishio S, Hayashi S, Yoshihara H, Kobayagawa H.

Hinyokika Kiyo. 1989 Nov;35(11):1839-45. Japanese.

PMID:
2618881
8.

Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.

Andress DL, Endres DB, Ott SM, Sherrard DJ.

Kidney Int Suppl. 1986 Feb;18:S87-90. No abstract available.

PMID:
3458004
9.

[Chronic aluminum intoxication in patients with terminal kidney failure on programmed hemodialysis (literature review)].

Milovanova LIu, Nikolaev AIu, Barashkov GK.

Ter Arkh. 2001;73(6):67-9. Review. Russian. No abstract available.

PMID:
11521528
10.
11.

Differences in pattern visual evoked potential (PVEP) between hemodialysis and peritoneal dialysis patients.

Storch RL, Storch S, London R, Pordy WT.

Clin Electroencephalogr. 1992 Oct;23(4):169-76.

PMID:
1395054
12.

Relationship of serum aluminum to serum creatinine and parathyroid hormone in chronic renal failure and transplant patients.

Mayor GH, Hourani MR, Makdani DD.

Proc Clin Dial Transplant Forum. 1977;7:86-90. No abstract available.

PMID:
356040
13.

Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.

Felsenfeld AJ.

ANNA J. 1985 Jun;12(3):189-91. No abstract available.

PMID:
3848318
14.

[Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].

Di Landro D, Zanatta GP, Simioni N, Pinzani A, Zotti D, Perin N, Bertoli M, Naso A, Ruffatti A, Gasparotto ML, et al.

Minerva Med. 1985 Mar 10;76(9-10):419-23. Italian. No abstract available.

PMID:
3982699
15.
16.

[Determination of the plasma aluminum concentration of hemodialysis patients].

Kuleva V, Petrov I, Antonov S, Kiriakov Z.

Vutr Boles. 1984;23(2):51-5. Bulgarian.

PMID:
6741112
17.

[Markers of bone pain in hemodialysis patients with renal insufficiency].

Oka F, Sagawa H, Yabe K, Okuyama A, Tachibana M, Noge T, Torizumi K, Okamoto S, Yasui M, Tuda T, et al.

Radioisotopes. 1988 Oct;37(10):572-5. Japanese.

PMID:
3264410
18.

Effect of citrate on serum aluminum concentrations in hemodialysis patients: a prospective study.

Lindberg JS, Copley JB, Koenig KG, Cushner HM.

South Med J. 1993 Dec;86(12):1385-8.

PMID:
8272917
19.

Trace elements in patients on chronic hemodialysis. 1. Plasma aluminium.

Shirai T, Imori H, Konomi G, Ikuta T, Minoda H, Nakao M.

Fukuoka Shika Daigaku Gakkai Zasshi. 1989;16(1):1-10. No abstract available.

PMID:
2632285
20.

Serum aluminum and continuous ambulatory peritoneal dialysis.

Wolf A, Graf H, Pinggera WF, Stummvoll HK, Meisinger V.

Ann Intern Med. 1980 Jan;92(1):130-1. No abstract available.

PMID:
7350863
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk